Changes to the Code
H.R. 1060 · Modern Authentication of Pharmaceuticals Act of 2025 · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
21 U.S.C. § 360eee Definitions
2 changes the bill asks for here, 2 carried out
- Carried out:
Section 581(14) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee(14)) is amended to read as follows:
(14) Product identifier.— The term “product identifier” means— (A) a standardized graphic that includes, in both human-readable form and on a machine-readable data carrier that conforms to the standards developed by a widely recognized international standards development …
- Carried out:
Section 581(28) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee(28)) is amended to read as follows:
(28) Verification or verify.— The term “verification” or “verify” means— (A) determining whether the product identifier affixed to, or imprinted upon, a package or homogeneous case corresponds to the standardized numerical identifier or lot number and expiration date assigned to …
§ 360eee(12)–(16)
Start of § 360eee to (11)(B) unchanged ·
(12) Prescription drug The term “prescription drug” means a drug for human use subject to section 353(b)(1) of this title.
(13) Product The term “product” means a prescription drug in a finished dosage form for administration to a patient without substantial further manufacturing (such as capsules, tablets, and lyophilized products before reconstitution), but for purposes of section 360eee–1 of this title, does not include blood or blood components intended for transfusion, radioactive drugs or radioactive biological products (as defined in section 600.3(ee) of title 21, Code of Federal Regulations) that are regulated by the Nuclear Regulatory Commission or by a State pursuant to an agreement with such Commission under section 2021 of title 42, imaging drugs, an intravenous product described in clause (xiv), (xv), or (xvi) of paragraph (24)(B), any medical gas (as defined in section 360ddd of this title), homeopathic drugs marketed in accordance with applicable guidance under this chapter, or a drug compounded in compliance with section 353a or 353b of this title.
(14) Product identifier[inserted: .—] [inserted: The term “product identifier” means—]
(A) [inserted: a standardized graphic that includes, in both human-readable form and on a machine-readable data carrier that conforms to the standards developed by a widely recognized international standards development organization, the standardized numerical identifier, lot number, and expiration date of the product; or]
(B) [inserted: a physical chemical identifier, possessing a unique physical or chemical substance or combination of substances, that—]
(i) [inserted: is in or on a product;]
(ii) [inserted: is machine readable; and]
(iii) [inserted: is intended to authenticate the product or a dosage form thereof.]
[struck: The term “product identifier” means a standardized graphic that includes, in both human-readable form and on a machine-readable data carrier that conforms to the standards developed by a widely recognized international standards development organization, the standardized numerical identifier, lot number, and expiration date of the product.]
(15) Quarantine The term “quarantine” means the storage or identification of a product, to prevent distribution or transfer of the product, in a physically separate area clearly identified for such use or through other procedures.
(16) Repackager The term “repackager” means a person who owns or operates an establishment that repacks and relabels a product or package for—
§ 360eee(27)–(29)
(16)(A)–(27)(E) unchanged ·
(F) did not knowingly provide false transaction information; and
(G) did not knowingly alter the transaction history.
(28) Verification or verify[inserted: .—] [inserted: The term “verification” or “verify” means—]
(A) [inserted: determining whether the product identifier affixed to, or imprinted upon, a package or homogeneous case corresponds to the standardized numerical identifier or lot number and expiration date assigned to the product by the manufacturer or the repackager, as applicable in accordance with section 582; or]
(B) [inserted: determining whether a product or a dosage form thereof is authentic using a physical chemical identifier described in paragraph (14)(B).]
[struck: The term “verification” or “verify” means determining whether the product identifier affixed to, or imprinted upon, a package or homogeneous case corresponds to the standardized numerical identifier or lot number and expiration date assigned to the product by the manufacturer or the repackager, as applicable in accordance with section 360eee–1 of this title.]
(29) Wholesale distributor The term “wholesale distributor” means a person (other than a manufacturer, a manufacturer’s co-licensed partner, a third-party logistics provider, or repackager) engaged in wholesale distribution (as defined in section 353(e)(4) of this title).
21 U.S.C. § 360eee–1 Requirements
3 changes the bill asks for here, 3 carried out
- Carried out:
in subparagraph (A)(ii), by striking
and
at the end; - Carried out:
by redesignating subparagraph (B) as subparagraph (C); and
- Carried out:
by inserting after subparagraph (A) the following:
(B) a physical chemical identifier shall be included in or on each dose of a product that is— (i) a controlled substance (as defined in section 102 of the Controlled Substances Act); (ii) in solid oral dosage form; and (iii) manufactured on or after the date that is five years …
§ 360eee–1(a)–(b)
Start of § 360eee–1 to (a)(9)(A) unchanged ·
(i) shall be included in a 2-dimensional data matrix barcode when affixed to, or imprinted upon, a package; and
(ii) shall be included in a linear or 2-dimensional data matrix barcode when affixed to, or imprinted upon, a homogeneous case;[struck: and]
(B) [inserted: a physical chemical identifier shall be included in or on each dose of a product that is—]
(i) [inserted: a controlled substance (as defined in section 102 of the Controlled Substances Act);]
(ii) [inserted: in solid oral dosage form; and]
(iii) [inserted: manufactured on or after the date that is five years after the date of enactment of the Modern Authentication of Pharmaceuticals Act of 2025; and]
[struck: (B)] [inserted: (C)] verification of the product identifier may occur by using human-readable or machine-readable methods.
(b) Manufacturer requirements
(1) Product tracing
(A) In general Beginning not later than January 1, 2015, a manufacturer shall—
Rest of § 360eee–1 unchanged ·